Enzymatica’s presentation at Stora Aktiedagarna now available online

On March 10, Sana Alajmovic presented Enzymatica AB at Stora Aktiedagarna in Stockholm, one of Sweden’s largest investor events organised by Aktiespararna. 

During the presentation, Sana Alajmovic provided an update on the company’s strategy and development, with particular focus on:

• Enzymatica’s continued international expansion

• The global market potential for ColdZyme

• The importance of continued clinical evidence and strong commercial partnerships

For investors and other stakeholders who were unable to follow the presentation live, it is now available to watch online.